Platinum-containing regimens for metastatic breast cancer.

about

Platinum-containing regimens for metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q38712631

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Platinum-containing regimens for metastatic breast cancer.

@en

type

Item

label

Platinum-containing regimens for metastatic breast cancer.

@en

prefLabel

Platinum-containing regimens for metastatic breast cancer.

@en

P1476

Platinum-containing regimens for metastatic breast cancer

@en

P2093

Davina Ghersi

http://www.w3.org/2001/XMLSchema#string

Harriet S Walker

http://www.w3.org/2001/XMLSchema#string

Jenna Morgan

http://www.w3.org/2001/XMLSchema#string

Melina L Willson

http://www.w3.org/2001/XMLSchema#string

Nicholas Wilcken

http://www.w3.org/2001/XMLSchema#string

Sam J Egger

http://www.w3.org/2001/XMLSchema#string

Sue Carrick

http://www.w3.org/2001/XMLSchema#string

P2860

Platinum containing regimens for metastatic breast cancer

Bias in meta-analysis detected by a simple, graphical test

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Practical methods for incorporating summary time-to-event data into meta-analysis

Formation and repair of interstrand cross-links in DNA

Triple-Negative Breast Cancer

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial.

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.

Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

P304

CD003374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/14651858.CD003374.PUB4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28643430

http://www.w3.org/2001/XMLSchema#string

P932

6481538

http://www.w3.org/2001/XMLSchema#string